Stock listing
BOATS:BMRA Biomerica, Inc. Stock
US listing (BOATS) of Biomerica, Inc. · home listing NASDAQ:BMRA
Follow Biomerica, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:BMRA
$1.73 USD +0.01 (+0.6%)
Close on Nov 2, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:BMRA
- Day range
- $1.72 – $1.77 USDNov 2, 2026
- Volume
- 2,881 sharesNov 2, 2026
- Market cap
- $7.96M USDAt the close on Nov 2, 2026 · price × 4.60M shares outstanding
- 52-week range
- $1.45 – $2.94 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $149,494 USDMedian day 11,100 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:BMRA · Home | $1.73 USD | +0.01 (+0.6%) | 2,881 | $1.772 | $1.772 | $1.715 | $1.72 | Close on Nov 2, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:BMRA · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.73 | +0.01 | +0.6% | $1.772 | $1.772 | $1.715 | 2,881 | |
| $1.72 | -0.02 | -1.1% | $1.695 | $1.735 | $1.68 | 10,215 | |
| $1.74 | -0.01 | -0.6% | $1.705 | $1.749 | $1.70 | 4,174 | |
| $1.75 | +0.04 | +2.3% | $1.72 | $1.771 | $1.705 | 3,879 | |
| $1.71 | -0.01 | -0.6% | $1.774 | $1.78 | $1.66 | 7,063 | |
| $1.72 | +0.04 | +2.4% | $1.67 | $1.79 | $1.67 | 10,412 | |
| $1.68 | 0.00 | 0.0% | $1.68 | $1.72 | $1.66 | 12,000 | |
| $1.68 | -0.03 | -1.8% | $1.66 | $1.71 | $1.66 | 2,000 | |
| $1.71 | -0.01 | -0.6% | $1.69 | $1.72 | $1.60 | 7,500 | |
| $1.72 | -0.04 | -2.3% | $1.77 | $1.79 | $1.60 | 6,000 | |
| $1.76 | -0.09 | -4.9% | $1.85 | $1.85 | $1.75 | 13,300 | |
| $1.85 | -0.03 | -1.6% | $1.83 | $1.95 | $1.81 | 13,200 | |
| $1.88 | +0.08 | +4.4% | $1.87 | $1.92 | $1.81 | 13,800 | |
| $1.80 | -0.05 | -2.7% | $1.83 | $1.86 | $1.76 | 18,600 | |
| $1.85 | +0.01 | +0.5% | $1.85 | $1.89 | $1.81 | 13,300 | |
| $1.84 | 0.00 | 0.0% | $1.90 | $1.90 | $1.84 | 4,900 | |
| $1.84 | -0.05 | -2.6% | $1.86 | $1.87 | $1.84 | 10,300 | |
| $1.89 | -0.02 | -1.0% | $1.91 | $1.91 | $1.86 | 6,600 | |
| $1.91 | -0.23 | -10.7% | $2.10 | $2.10 | $1.90 | 34,700 | |
| $2.14 | +0.09 | +4.4% | $2.09 | $2.14 | $2.01 | 11,100 | |
| $2.05 | -0.09 | -4.2% | $2.06 | $2.19 | $2.02 | 33,900 | |
| $2.14 | -0.10 | -4.5% | $2.19 | $2.23 | $2.14 | 8,400 | |
| $2.24 | -0.02 | -0.9% | $2.25 | $2.25 | $2.24 | 2,200 | |
| $2.26 | -0.04 | -1.7% | $2.32 | $2.34 | $2.25 | 11,400 | |
| $2.30 | -0.09 | -3.8% | $2.35 | $2.35 | $2.30 | 2,500 | |
| $2.39 | +0.07 | +3.0% | $2.30 | $2.39 | $2.29 | 7,100 | |
| $2.32 | -0.14 | -5.7% | $2.43 | $2.64 | $2.18 | 58,600 | |
| $2.46 | -0.15 | -5.7% | $2.60 | $2.64 | $2.44 | 51,000 | |
| $2.61 | -0.17 | -6.1% | $2.79 | $2.84 | $2.58 | 37,600 | |
| $2.78 | +0.18 | +6.9% | $2.60 | $2.78 | $2.57 | 42,000 | |
| $2.60 | +0.09 | +3.6% | $2.55 | $2.60 | $2.41 | 23,100 | |
| $2.51 | +0.15 | +6.4% | $2.34 | $2.52 | $2.30 | 75,800 | |
| $2.36 | -0.01 | -0.4% | $2.31 | $2.41 | $2.26 | 37,500 | |
| $2.37 | +0.07 | +3.0% | $2.27 | $2.42 | $2.27 | 13,700 | |
| $2.30 | -0.06 | -2.5% | $2.36 | $2.39 | $2.28 | 17,500 | |
| $2.36 | +0.12 | +5.4% | $2.26 | $2.41 | $2.18 | 28,100 | |
| $2.24 | +0.01 | +0.4% | $2.25 | $2.29 | $2.13 | 11,900 | |
| $2.23 | -0.04 | -1.8% | $2.17 | $2.25 | $2.17 | 15,400 | |
| $2.27 | -0.07 | -3.0% | $2.35 | $2.35 | $1.97 | 21,400 | |
| $2.34 | +0.03 | +1.3% | $2.27 | $2.38 | $2.21 | 85,200 | |
| $2.31 | +0.09 | +4.1% | $2.27 | $2.35 | $2.21 | 54,400 | |
| $2.22 | +0.02 | +0.9% | $2.21 | $2.33 | $2.17 | 58,900 | |
| $2.20 | +0.11 | +5.3% | $2.05 | $2.20 | $1.98 | 67,700 | |
| $2.09 | 0.00 | 0.0% | $2.11 | $2.15 | $1.94 | 34,400 | |
| $2.09 | -0.05 | -2.3% | $2.15 | $2.16 | $2.01 | 51,100 | |
| $2.14 | +0.04 | +1.9% | $2.13 | $2.15 | $2.01 | 131,900 | |
| $2.10 | +0.41 | +24.3% | $1.71 | $2.35 | $1.71 | 3,273,300 | |
| $1.69 | -0.08 | -4.5% | $1.70 | $1.78 | $1.69 | 8,500 | |
| $1.77 | +0.09 | +5.4% | $1.66 | $1.81 | $1.66 | 16,800 | |
| $1.68 | +0.07 | +4.3% | $1.61 | $1.69 | $1.60 | 8,500 | |
| $1.61 | +0.02 | +1.3% | $1.58 | $1.63 | $1.58 | 10,000 | |
| $1.59 | +0.07 | +4.6% | $1.55 | $1.59 | $1.52 | 3,500 | |
| $1.52 | -0.08 | -5.0% | $1.51 | $1.55 | $1.50 | 7,500 | |
| $1.60 | +0.04 | +2.6% | $1.60 | $1.61 | $1.56 | 6,700 | |
| $1.56 | -0.02 | -1.3% | $1.63 | $1.65 | $1.56 | 4,600 | |
| $1.58 | -0.04 | -2.5% | $1.58 | $1.58 | $1.54 | 8,800 | |
| $1.62 | +0.05 | +3.2% | $1.62 | $1.65 | $1.61 | 5,800 | |
| $1.57 | 0.00 | 0.0% | $1.57 | $1.63 | $1.57 | 2,300 | |
| $1.57 | -0.06 | -3.7% | $1.56 | $1.58 | $1.56 | 1,500 | |
| $1.63 | +0.02 | +1.2% | $1.60 | $1.68 | $1.60 | 9,500 | |
| $1.61 | +0.01 | +0.6% | $1.61 | $1.61 | $1.61 | 600 | |
| $1.60 | -0.02 | -1.2% | $1.55 | $1.60 | $1.55 | 4,600 | |
| $1.62 | +0.09 | +5.9% | $1.60 | $1.62 | $1.59 | 1,500 | |
| $1.53 | 0.00 | 0.0% | $1.53 | $1.55 | $1.45 | 14,600 | |
| $1.53 | +0.04 | +2.7% | $1.49 | $1.59 | $1.45 | 6,600 |
- Ticker
- BOATS:BMRA
- Asset type
- Stock
- Sector
- Health care
- Industry
- Diagnostics & research services
- Exchange
- BOATS
- Currency
- USD
What changed lately
Latest news release · Oct 16, 2026
Biomerica Reports First Quarter Fiscal 2027 Financial Results
Latest deck · March 2026
Investor Presentation (March 2026)
Investor deck · 26 slides
Latest news
Biomerica Reports First Quarter Fiscal 2027 Financial Results
Oct 16, 2026
Closed $1.85 (-1.6%) on Oct 16, 2026
Biomerica Reports Fiscal 2026 Year-End Financial Results
Sep 1, 2026
Closed $2.09 (0.0%) on Sep 1, 2026
Annual Report for Fiscal Year Ending May 31, 2026 (Form 10-K)
Aug 31, 2026
Closed $2.09 (0.0%) on Sep 1, 2026
Biomerica Announces $2.23 Million Financing
Aug 28, 2026
Closed $2.14 (+1.9%) on Aug 28, 2026
Biomerica Lands a $1.75 Million CDMO Master Services Agreement for IVD Diagnostic Development
May 28, 2026
Closed $2.43 (-1.2%) on May 28, 2026
Biomerica’s inFoods® IBS Data Accepted for Presentation at Digestive Disease Week 2026
Apr 29, 2026
Closed $2.16 (-0.9%) on Apr 29, 2026
Biomerica Announces Medicare Administrative Contractor Confirmation of Individual Claim Review for inFoods IBS, Opening a Scalable Medicare Commercialization Pathway
Apr 17, 2026
Closed $2.18 (-0.9%) on Apr 17, 2026
Biomerica Launches inFoods IBS in Canada through Partnerships with Phoenix Airmid Biomedical and CanAlt Health Labs
Apr 15, 2026
Closed $2.11 (+0.5%) on Apr 15, 2026
Biomerica Reports Third Quarter Fiscal 2026 Financial Results
Apr 13, 2026
Closed $2.08 (-2.3%) on Apr 13, 2026
Biomerica Receives First Commercial Order for its H. pylori test from one of the Largest Clinical Laboratory Chains in Europe
Mar 19, 2026
Closed $2.08 (-2.8%) on Mar 19, 2026
Financings
Private placement of shares of common stock
Sep 1, 2026
Closed: US$2.23M raised · US$1.6 a share
Buyers: B. Riley Principal Capital; Executives and employees of B. Riley Securities, Inc.; Chief Executive Officer; Board of Directors (all members of the Company's Board of Directors); B. Riley Principal Capital, LLC; Biomerica Board of Directors (all members participated)
Insiders: All members of Biomerica's Board of Directors participated
Use of proceeds: Strengthen the balance sheet and fund operations while the Board evaluates potential strategic opportunities
Decks
Investor Presentation (March 2026)
Investor deck · 26 slides · March 2026
Investor Presentation (February 2026)
Investor deck · 27 slides · February 2026
Investor Presentation (September 2025)
Investor deck · 29 slides · September 2025
Investor Presentation (July 2025)
Investor deck · 30 slides · July 2025
Biomerica, Inc. on 6ix
- Sector
- Health care
- Industry
- Diagnostics & research services
- News releases
- 22 in the last 12 months · 101 in all · newest Oct 16, 2026 · oldest 2019
- Decks
- 19 decks · latest March 2026
Where Biomerica, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:BMRA · Home listing | NASDAQ | United States | USD |
| BOATS:BMRA · This page | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Biomerica, Inc.